Highlights from the Week of 12th October – 19th October in the world of pharma and healthcare!

Highlights from the week of 12th Oct - 19th Oct UCB ( FDA, Approval ) FDA approves UCB's ZILBRYSQ, an once-daily autoinjector, to treat gMG in adults who are anti-AChR antibody positive Genentech ( FDA, Approval ) Genentech's ENSPRYNG, the first and only at-home subcutaneous treatment option, gets FDA approval indicated to treat adults with TED Viatris ( FDA, Approval ) FDA gives approval to Viatris' RYZUMVI to treat presbyopia in adults, expanding the product's indications Revolution Medicines ( CHMP, Positive Opinion ) Revolution Medicines receives positive CHMP opinion for its RASONQUE once-daily oral tablets to treat adults with metastatic pancreatic adenocarcinoma All logos and trademarks remain the intellectual properties of their respective owners

Connect with us

Please fill in the information below, and we'll get back to you.